Skip to main content
Premium Trial:

Request an Annual Quote

GATC Biotech, Complete Genomics Ink Sequencing Pact

NEW YORK (GenomeWeb News) – GATC Biotech and Complete Genomics said today that they are collaborating to sequence several human genomes from samples provided by GATC.

Under the agreement, Mountain View, Calif.-based Complete Genomics will sequence and assemble the genomes and provide GATC with detected variants including single nucleotide polymorphisms and indels.

GATC, based in Konstanz, Germany, will then perform bioinformatics analyses such as comparing the variant data of different genomes; and will refine the data with the intent of providing researchers and clinicians with relevant genomic details to advance their understanding of the genetic causes of diseases.

"To achieve our 100-Human-Genome-Project goal, evaluating Complete Genomics' human genome sequencing technology is a logical step," Peter Pohl, CEO of GATC Biotech, said in a statement.

Financial terms of the agreement were not disclosed.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.